HOME >> MEDICINE >> NEWS
Columbia neurobiology fellow wins major career award from 2002 Burroughs Wellcome funding program

Kristin Scott, Ph.D., a postdoctoral fellow and research scientist in the Center for Neurobiology and Behavior at Columbia University Health Sciences, has been named a 2002 Burroughs Wellcome Fund career awardee in the biomedical sciences. The Burroughs Wellcome Fund Career Awards Program was established in 1995 to foster the development of promising biomedical researchers early in their careers and to help them make the transition from postdoctoral researcher to full-fledged independent investigator. Dr. Scott, who will receive a $500,000 grant from the Burroughs Wellcome Fund (BWF) to study taste representation in the brains of Drosophila (a type of fruit fly commonly used in biomedical research), is one of just 17 investigators across the United States named to this year's roster of winners.

A 1989 graduate of the University of Chicago with a bachelor's degree in biology, Dr. Scott subsequently pursued doctoral studies in neurobiology at the University of California at San Diego, where she studied phototransduction (the conversion of light into sensory stimuli) in Drosophila under the tutelage of Dr. Charles Zuker. Upon receiving her Ph.D. in 1998, Dr. Scott joined Columbia as a postdoctoral researcher in the laboratory of University Professor Richard Axel, M.D.-where today she investigates the gustatory system (mechanisms of taste) in Drosophila-at the Center for Neurobiology and Behavior. Dr. Scott is the recipient of a 1999 Life Sciences Research Fellowship at Columbia and has published articles about her research in a number of scholarly journals and publications, including Cell, the Proceedings of the National Academy of Sciences, and Nature.

"I am thrilled that Burroughs Wellcome has chosen to honor and perpetuate my work through the career awards program," said Dr. Scott. "Their long-term support will enable me to pursue my research systematically and comprehensively across two different stages of my career and to unravel the mystery of e
'"/>

Contact: Leslie Boen
lsb2001@columbia.edu
Columbia University Medical Center
29-Jul-2002


Page: 1 2

Related medicine news :

1. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
2. Columbia study shows widely used artery clearing device does not help patients during heart attack
3. Columbia study finds hemophilia therapy dramatically improves outcomes for bleeding stroke
4. First US kidney cancer vaccine trial underway at Columbia
5. RelayHealth selected by Columbia University to link doctors and patients online
6. Harlem Hospital Center, Columbia affiliate, recognized for efforts to fight glaucoma
7. Research by scientists affiliated with the Earth Institute at Columbia University
8. Columbia Univ. Medical Center wins highly competitive stroke grant from NIH
9. Brain Science Institute at Columbia University established by Kavli Foundation gift
10. Earth Institute at Columbia University hosts State of the Planet 2004
11. The Gerontological Society of America confers 2003 Lawton Award to Columbia Universitys Gurland

Post Your Comments:
(Date:11/26/2014)... 2014 GI for Life announced today, ... in prices of their popular nutritional supplements: ColoVite ... . Discounts of 40% will be offered for ... Life’s proprietary ColoVite supplement is a scientifically formulated vitamin ... health. One easy-to-take colon vitamin with ALL the nutrients ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Call 866-997-4948 ... requirements or email the details on sales(at)researchmoz(dot)us , ... and drug discovery market 2014" with deep study of ... the result of high blood sugar. The global glucose ... linked to the growing number of diabetics in the ...
(Date:11/26/2014)... News Facts , Lexmark’s Perceptive ... 2014 in Chicago. The company will demonstrate solutions ... photos, videos and documents found throughout the healthcare ... more about these innovative medical content management solutions ... – that enable more informed clinical decisions, promote ...
(Date:11/26/2014)... TUESDAY, Nov. 25, 2014 (HealthDay News) -- Teens ... likely to abuse those drugs than other teens, ... the need to conduct substance abuse assessments on ... researchers said. "Prescribers and parents don,t realize ... a professor at the University of Michigan School ...
(Date:11/26/2014)... need to take an active role in protecting their ... must make sure sports-playing teens have the right protective ... the American Migraine Foundation and a professor of medicine ... Ariz. in an American Migraine Foundation, said in a ... teens sports needs to have appropriate training. Teen sports ...
Breaking Medicine News(10 mins):Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2
(Date:11/26/2014)... and LONDON , Nov. 25, ... AstraZeneca (NYSE: AZN ) today announced that AMAGINE-2 ... doses of brodalumab in more than 1,800 patients with moderate-to-severe ... Stelara ® (ustekinumab) and placebo at week 12. Brodalumab ... analysis group were each shown to be superior to Stelara ...
(Date:11/26/2014)... China , Nov. 26, 2014 / -- China Nepstar Chain ... "Company"), a leading retail drugstore chain in ... operated stores, today announced the appointment of Ms. ... Officer, effective immediately. Ms.Zhang has over ... joined Nepstar in March 1999. Prior to Ms. Zhang,s ...
(Date:11/24/2014)... -- Juno Therapeutics today announced that the FDA ... JCAR015 chimeric antigen receptor product candidate.  The designation ... B-cell acute lymphoblastic leukemia and was filed by ... where Phase 1 clinical trials are currently underway. ... news for patients who may benefit from the ...
Breaking Medicine Technology:Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 2China Nepstar Chain Drugstore Appoints Ms. Rebecca Yingnan Zhang as Chief Operating Officer 3Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3
Cached News: